Insider Buy/Sell Details for the Healthcare Sector — February 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1586)
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
233,038
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
50
Price
$3.05
Total Value
$152.50
Shares Held After
233,088
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
500
Price
$3.05
Total Value
$1.52K
Shares Held After
233,138
% of Holdings
0.2%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
200
Price
$3.06
Total Value
$612.00
Shares Held After
233,638
% of Holdings
0.1%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
100
Price
$3.04
Total Value
$304.00
Shares Held After
233,838
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
4
Price
$3.05
Total Value
$12.20
Shares Held After
233,938
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
4
Price
$3.05
Total Value
$12.20
Shares Held After
233,942
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
10
Price
$3.05
Total Value
$30.50
Shares Held After
233,946
% of Holdings
0.0%
NanoVibronix, Inc. Common Stock (FEED)
BANK OF AMERICA CORP /DE/ — 10% Owner
Shares
100
Price
$3.05
Total Value
$305.00
Shares Held After
233,956
% of Holdings
0.0%
Zentalis Pharmaceuticals, Inc. (ZNTL)
Vultaggio Vincent — PAO and PFO
Shares
2,540
Price
$2.55
Total Value
$6.48K
Shares Held After
187,286
% of Holdings
1.3%
OCULAR THERAPEUTIX, INC (OCUL)
Notman Donald — Chief Operating Officer
Shares
5,455
Price
$9.14
Total Value
$49.86K
Shares Held After
383,837
% of Holdings
1.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Shares
4,714
Price
$25.63
Total Value
$120.82K
Shares Held After
110,003
% of Holdings
4.1%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Shares
19,379
Price
$25.24
Total Value
$489.13K
Shares Held After
114,717
% of Holdings
14.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Shares
8,562
Price
$24.97
Total Value
$213.79K
Shares Held After
134,096
% of Holdings
6.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: SVP General Counsel and Corporate Secretary
Shares
7,983
Price
$25.50
Total Value
$203.55K
Shares Held After
142,658
% of Holdings
5.3%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
1,890
Price
$44.57
Total Value
$84.24K
Shares Held After
3,559,765
% of Holdings
0.1%
Adaptive Biotechnologies Corp (ADPT)
ROBINS HARLAN S — Chief Scientific Officer
Shares
34,668
Price
$18.60
Total Value
$644.82K
Shares Held After
1,187,644
% of Holdings
2.8%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
100
Price
$66.89
Total Value
$6.69K
Shares Held After
183,371
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
1,108
Price
$66.15
Total Value
$73.29K
Shares Held After
183,471
% of Holdings
0.6%
Apogee Therapeutics, Inc. (APGE)
Henderson Jane — Chief Financial Officer
Shares
792
Price
$65.21
Total Value
$51.65K
Shares Held After
184,579
% of Holdings
0.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Vairavan Latha — SVP Chief Financial Officer
Shares
1,320
Price
$25.50
Total Value
$33.66K
Shares Held After
63,607
% of Holdings
2.0%
Arcutis Biotherapeutics, Inc. (ARQT)
Edwards Larry Todd — Reporting Person's title: EVP Chief Commercial Officer
Shares
2,052
Price
$25.50
Total Value
$52.32K
Shares Held After
148,865
% of Holdings
1.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Welgus Howard G. — Director
Shares
10,000
Price
$25.05
Total Value
$250.48K
Shares Held After
59,744
% of Holdings
14.3%
Arcutis Biotherapeutics, Inc. (ARQT)
Watanabe Todd — Director
Shares
19,833
Price
$25.50
Total Value
$505.71K
Shares Held After
721,306
% of Holdings
2.7%
Arcutis Biotherapeutics, Inc. (ARQT)
Burnett Patrick — Reporting Person's Title: Executive Vice President and Chief Medical Officer
Shares
3,675
Price
$25.50
Total Value
$93.71K
Shares Held After
90,445
% of Holdings
3.9%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
124,998
Price
$18.44
Total Value
$2.30M
Shares Held After
2,459,245
% of Holdings
4.8%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
1,890
Price
$44.57
Total Value
$84.24K
Shares Held After
3,559,765
% of Holdings
0.1%
SI-BONE, Inc. (SIBN)
DUNN JEFFREY W — Director
Shares
337
Price
$16.42
Total Value
$5.53K
Shares Held After
9,970
% of Holdings
3.3%
Kiniksa Pharmaceuticals International, plc (KNSA)
Quart Barry D — Director
Shares
830
Price
$45.00
Total Value
$37.35K
Shares Held After
12,546
% of Holdings
6.2%
Allogene Therapeutics, Inc. (ALLO)
Parker Geoffrey M. — CHIEF FINANCIAL OFFICER
Shares
24,001
Price
$1.76
Total Value
$42.24K
Shares Held After
1,252,795
% of Holdings
1.9%
Allogene Therapeutics, Inc. (ALLO)
Chang David D — Director
Shares
95,269
Price
$1.80
Total Value
$171.48K
Shares Held After
5,185,862
% of Holdings
1.8%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
23
Price
$197.19
Total Value
$4.54K
Shares Held After
43,187
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
381
Price
$196.36
Total Value
$74.81K
Shares Held After
43,210
% of Holdings
0.9%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
23
Price
$195.60
Total Value
$4.50K
Shares Held After
43,591
% of Holdings
0.1%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
1
Price
$192.18
Total Value
$192.18
Shares Held After
43,614
% of Holdings
0.0%
LIGAND PHARMACEUTICALS INC (LGND)
KOZARICH JOHN W — Director
Shares
39
Price
$191.00
Total Value
$7.45K
Shares Held After
43,615
% of Holdings
0.1%
Allogene Therapeutics, Inc. (ALLO)
Beneski Benjamin Machinas — SVP, Chief Technical Officer
Shares
7,549
Price
$1.73
Total Value
$13.06K
Shares Held After
210,172
% of Holdings
3.5%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
736
Price
$46.63
Total Value
$34.32K
Shares Held After
12,965
% of Holdings
5.4%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
4,064
Price
$46.03
Total Value
$187.07K
Shares Held After
13,701
% of Holdings
22.9%
Maze Therapeutics, Inc. (MAZE)
Bachrodt Amy — SVP, Finance
Shares
200
Price
$44.15
Total Value
$8.83K
Shares Held After
17,765
% of Holdings
1.1%
LEXICON PHARMACEUTICALS, INC. (LXRX)
Invus Global Management, LLC — Director
Shares
1,538,462
Price
$1.30
Total Value
$2.00M
Shares Held After
1,538,462
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
100
Price
$47.23
Total Value
$4.72K
Shares Held After
0
% of Holdings
100.0%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
5,936
Price
$46.37
Total Value
$275.27K
Shares Held After
100
% of Holdings
98.3%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
8,364
Price
$45.89
Total Value
$383.82K
Shares Held After
6,036
% of Holdings
58.1%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D & CMO
Shares
600
Price
$44.20
Total Value
$26.52K
Shares Held After
14,400
% of Holdings
4.0%
ABEONA THERAPEUTICS INC. (ABEO)
Silverstein Christine Berni — Director
Shares
20,070
Price
$5.09
Total Value
$102.17K
Shares Held After
137,722
% of Holdings
12.7%
Tempus AI, Inc. (TEM)
Epstein David R — Director
Shares
370
Price
$59.41
Total Value
$21.98K
Shares Held After
26,051
% of Holdings
1.4%
Absci Corp (ABSI)
Jonasson Zachariah — CFO / CBO
Shares
17,496
Price
$2.99
Total Value
$52.31K
Shares Held After
383,538
% of Holdings
4.4%
Absci Corp (ABSI)
McClain Sean — Director
Shares
26,761
Price
$2.99
Total Value
$80.02K
Shares Held After
8,334,567
% of Holdings
0.3%
ENSIGN GROUP, INC (ENSG)
SMITH BARRY M — Director
Shares
700
Price
$171.54
Total Value
$120.08K
Shares Held After
23,552
% of Holdings
2.9%
Showing 1451–1500 of 1586 transactions (page 30 of 32)